Clinical Center; Notice of Closed Meeting, 11660-11661 [2013-03643]

Download as PDF 11660 Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Yvonne Bennett, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5199, MSC 7846, Bethesda, MD 20892, 301–379–3793, bennetty@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: February 12, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2013–03638 Filed 2–15–13; 8:45 am] Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Closed Meeting BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Dated: February 12, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. National Institute of Biomedical Imaging And Bioengineering; Notice of Closed Meeting [FR Doc. 2013–03642 Filed 2–15–13; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Eunice Kennedy Shriver National Institute Of Child Health & Human Development; Notice of Closed Meeting TKELLEY on DSK3SPTVN1PROD with NOTICES Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel;‘‘Vulvodynia.’’ Date: March 6, 2013. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn Express, 1775 Rockville Pike, Rockville, MD 20852. Contact Person: Dennis E. Leszczynski, Ph.D., Scientific Review Officer, Division of Scientific Review, National Institute of Child Health, and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301–435–2717, leszcyd@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) VerDate Mar<15>2010 17:49 Feb 15, 2013 Jkt 229001 Name of Committee: National Institute of Biomedical Imaging and Bioengineering Special Emphasis Panel; NIH–NIBIB LRP Review Meeting (2013–08) Date: April 5, 2013. Time: 10:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: John K. Hayes, Ph.D., Scientific Review Officer, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, 6707 Democracy Boulevard, Room 959, Bethesda, MD 20892, 301–451–3398, hayesj@mail.nih.gov. Dated: February 12, 2013. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–03639 Filed 2–15–13; 8:45 am] BILLING CODE 4140–01–P PO 00000 National Institutes of Health Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Child Health and Human Development Special Emphasis Panel; Heart Placental Axis Development and Prevention of Cardiovascular Birth Defects. Date: March 12, 2013. Time: 2:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 5B01, 6100 Executive Boulevard, Rockville, MD 20852 (Telephone Conference Call). Contact Person: Peter Zelazowski, Ph.D., Scientific Review Officer, Division of Scientific Review, Eunice Kennedy Shriver National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5B01, Bethesda, MD 20892, 301–435–6902, peter.zelazowski@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: February 12, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–03637 Filed 2–15–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Clinical Center; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is Frm 00039 Fmt 4703 Sfmt 4703 E:\FR\FM\19FEN1.SGM 19FEN1 Federal Register / Vol. 78, No. 33 / Tuesday, February 19, 2013 / Notices hereby given of a meeting of the Board of Scientific Counselors of the NIH Clinical Center. The meeting will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the CLINICAL CENTER, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors of the NIH Clinical Center. Date: March 4–5, 2013. Time: 8:00 a.m. to 12:00 p.m. Agenda: To review and evaluate the Department of Laboratory Medicine. Place: National Institutes of Health, Building 10, 10 Center Drive, Room 4–2551, Bethesda, MD 20892. Contact Person: David K. Henderson, MD, Deputy Director for Clinical Care, Office of the Director, Clinical Center, National Institutes of Health, Building 10, Room 6– 1480, Bethesda, MD 20892, (301) 496–3515. Dated: February 12, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–03643 Filed 2–15–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Request for Information: Main Study Design for the National Children’s Study AGENCY: National Institutes of Health, HHS. ACTION: Notice. The Eunice Kennedy Shriver National Institute for Child Health and Human Development (NICHD), National Institutes of Health (NIH), is issuing a Request for Information (RFI) as part of the National Children’s Study’s (NCS) effort to engage communities and receive public input on specific design questions for incorporation into the Main Study Design of the NCS. The information obtained from RFI responses will be used to guide the construction of decision points or parameters for the Main Study design TKELLEY on DSK3SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:49 Feb 15, 2013 Jkt 229001 over the next 12–18 months. This RFI was preceded by a workshop with the National Academy of Sciences which posed similar questions. For background information on this workshop, please visit: https://www.nationalchildrens study.gov/research/workshops/Pages/ nationalacademyofsciences workshop.aspx. RFI Release Date is February 11, 2013. Response Close Date is February 25, 2013. ADDRESSES: To respond by February 25, 2013, please submit comments via email to NCS_RFI@mail.nih.gov. Please include citations for any references or reports that can be used as source material. DATES: FOR FURTHER INFORMATION CONTACT: Questions about this request for information may be directed to Kate Winseck, MSW, The National Children’s Study, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, 6100 Executive Blvd., Rm. 5C01, Bethesda, MD 20891, NCS_RFI@mail.nih.gov, 301–594–9147. SUPPLEMENTARY INFORMATION: The National Children’s Study is a congressionally mandated longitudinal birth cohort study intended to examine the effects of environmental exposures on the growth, development, and wellbeing of children. The NCS was mandated by the Children’s Health Act of 2000 (Pub. L. 106–310). The Study consists of several components, including: a pilot or Vanguard Study, a Main Study focused on exposureresponse relationships, substudies embedded in the Vanguard Study or the Main Study, and formative research projects. Data collection for the Vanguard Study began in January 2009. The design was changed in 2010 from a door-to-door household recruitment model to include an Alternate Recruitment Study (ARS). The ARS tested three different recruitment strategies that differed as to initial point of contact with potential participants— direct outreach, household-based through an NCS contractor, and provider-based through a licensed health care practitioner. Currently the NCS is testing, through Provider-Based Sampling Substudy, a further refinement of the provider-based sampling and recruitment using hospitals and birthing centers in addition to clinics and health care provider offices that are sampled. PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 11661 Between the summer of 2011 and the fall of 2012, the NCS held a series of meetings with federal and non-federal statistical sampling experts and others to discuss the most effective sampling approach and design for the Main Study. The NCS had multiple separate discussions and consultations with additional individuals and organizations. Based on these extensive discussions and consultations, the NCS is proposing the use of a multi-stage probability sample for the Main Study. The NCS plans to enroll women through multiple entry points into the Main Study, such as perinatally at hospitals and birthing centers, and prenatally through prenatal care providers. Additionally, women whose children are already enrolled will be followed as a preconception sample of subsequent births. Lastly, about 10% of the total number of participants to be recruited would be set aside for recruitment of a convenience sample for populations with characteristics or exposures of particular scientific interest that would likely be underrepresented in the other strata. The questions solicited in this RFI focus on how much the NCS should emphasize prenatal data collection, and what the NCS could anticipate gaining through the prospective data collection compared to retroactive data acquisition and the use of extant sources such as medical records, other databases and modeling. The issue is not whether to have a prenatal stratum, but what proportion of NCS resources should be devoted to the effort. Responses to this RFI will be used to inform the Main Study design. Proposed Main Study Design 1. Goals and Outcomes The primary objective of the NCS is to examine relationships among exposures and outcomes that affect children’s health and development. These factors include environmental exposures (with a broad definition of environment) and biological/genetic context. The NCS is not a study in a conventional sense. It will primarily function as a high quality data collection platform for researchers to explore hypotheses, access biospecimens and environmental samples, and analyze data. The Study’s objectives stated in the Children’s Health Act of 2000 are presented, along with the respective design considerations, in Table 1. E:\FR\FM\19FEN1.SGM 19FEN1

Agencies

[Federal Register Volume 78, Number 33 (Tuesday, February 19, 2013)]
[Notices]
[Pages 11660-11661]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-03643]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Clinical Center; Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is

[[Page 11661]]

hereby given of a meeting of the Board of Scientific Counselors of the 
NIH Clinical Center.
    The meeting will be closed to the public as indicated below in 
accordance with the provisions set forth in section 552b(c)(6), Title 5 
U.S.C., as amended for the review, discussion, and evaluation of 
individual intramural programs and projects conducted by the CLINICAL 
CENTER, including consideration of personnel qualifications and 
performance, and the competence of individual investigators, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.

    Name of Committee: Board of Scientific Counselors of the NIH 
Clinical Center.
    Date: March 4-5, 2013.
    Time: 8:00 a.m. to 12:00 p.m.
    Agenda: To review and evaluate the Department of Laboratory 
Medicine.
    Place: National Institutes of Health, Building 10, 10 Center 
Drive, Room 4-2551, Bethesda, MD 20892.
    Contact Person: David K. Henderson, MD, Deputy Director for 
Clinical Care, Office of the Director, Clinical Center, National 
Institutes of Health, Building 10, Room 6-1480, Bethesda, MD 20892, 
(301) 496-3515.

    Dated: February 12, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-03643 Filed 2-15-13; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.